Skin care brand Murad has signed a new 12-year lease and committed to a $35 million investment that will result in a new corporate headquarters in El Segundo, Calif., located just a few blocks away from the company’s current location.
There is as much as $10 billion in branded pharmaceutical sales that could make the switch from prescription-only to over-the counter in the next five years, suggested Joseph Papa, Perrigo chairman, CEO and president, to analysts on Tuesday.
Sato Pharmaceutical, maker of ZenTrip, an over-the-counter motion sickness remedy, recently completed an outdoor urban panel promotion with Duane Reade drug stores in New York, driving trial to the remedy’s thin-film medicated strip.
According to a recent Prevention survey, 74% of women are interested in knowing more about how their digestive system works, but almost half surveyed believe that digestive health is a taboo subject people are uncomfortable discussing.
The seventh annual Delete Blood Cancer Gala at Cipriani Wall Street broke all records of previous years and raised $3.7 million to support the fight against leukemia and other blood-related cancers. The money raised jointly by beauty company Coty and Delete Blood Cancer, part of the world's largest bone marrow donor center, will help register 55,000 new bone marrow donors and help patients worldwide.
The Food and Drug Administration may soon find itself in another Plan-B-generated quandary — the complications around granting a three-year marketing exclusivity for a medicine that is both prescription-only and over-the-counter, according to an FDA Law Blog posted Sunday by Hyman, Phelps & McNamara.
The five associations representing the dietary supplement industry on Monday requested that the Food and Drug Administration issue revised guidance on new dietary ingredient notifications, with a specific focus on the information to be included to identify the new dietary ingredient.
In recognition of "Melanoma Monday," L'Oréal Paris has released a new survey on melanoma awareness and prevention among women of all skin tones, and announced a philanthropic alliance with the Melanoma Research Alliance.